
    
      PRIMARY OBJECTIVES:

      I. To determine if copper Cu-64 TP3805 (Cu-64-TP3805) shall image urothelial carcinoma (UC)
      as confirmed by postsurgical or biopsy histology.

      SECONDARY OBJECTIVES:

      I. To determine blood clearance of Cu-64-TP3805. II. To determine in vivo stability of
      Cu-64-TP3805.

      TERTIARY:

      I. To determine if Cu-64-TP3805 is bound to malignant cells and if it is internalized.
    
  